Next Article in Journal
COVID-19 Safety: Perspectives from Dental Students
Previous Article in Journal
Efficacy of the CALM® Algorithm in Reducing Motion-Induced Artifacts in CBCT Imaging: A Fractal Dimension Analysis of Trabecular Bone
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Dentistry Journal
Volume 12
Issue 8
10.3390/dj12080263
dentistry-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Systematic Review

Hyaluronic Acid in Bone Regeneration: Systematic Review and Meta-Analysis

by
Claudia Lorenzi
1,2,
Andrea Leggeri
2,
Ilaria Cammarota
2,
Paolo Carosi
1,2,*,
Vincenzo Mazzetti
2 and
Claudio Arcuri
1
1
Department of Clinical Science and Translational Medicine, University of Rome Tor Vergata, 00133 Rome, Italy
2
Department of Chemical Science and Technologies, University of Rome Tor Vergata, 00133 Rome, Italy
*
Author to whom correspondence should be addressed.
Dent. J. 2024, 12(8), 263; https://doi.org/10.3390/dj12080263
Submission received: 27 June 2024 / Revised: 20 July 2024 / Accepted: 13 August 2024 / Published: 19 August 2024
(This article belongs to the Special Issue Bone Regeneration and Tissue Reconstruction in Dentistry)
Browse Figures
Versions Notes

Abstract

:
Aim: The aim of this systematic review and meta-analysis was to assess possible histomorphometric differences in new bone formation and in remaining graft particles when hyaluronic acid (HA) was added and mixed with graft materials in bone regeneration. Materials and methods: This review was registered at the International Prospective Register of Systematic Reviews (PROSPERO) of the National Institute of Health Research (registration number CRD42024530030). Electronic research was performed, and involved studies published up to 29 February 2024 using a specific word combination. The primary outcome was to assess possible histomorphometric differences in new bone formation and in remaining graft particles when HA was added and mixed with graft materials in bone regeneration. The search resulted in 138 potential studies. Meta-analyses were performed using the fixed and random effects model to identify significant changes in new bone formation and in the remaining graft particles. Results: After screening procedures, only three randomized controlled trials fulfilled the inclusion criteria and were selected for qualitative and quantitative analysis. The effect size of HA in the new bone formation was not statistically significant at 95% CI (Z = 1.734, p-value = 0.083, 95 % CI -,399; 6516). The effect size of HA in the remaining graft particles was not statistically significant at 95% CI (Z = −1.042, p-value = 0.297, CI -,835; 255). Conclusions: Within the limitations of the present systematic review and meta-analysis, the addition of HA to bone graft did not result in significant changes in bone regeneration procedures in terms of new bone formation and residues, even if the included studies showed encouraging and promising results.

1. Introduction

Guided bone regeneration (GBR) can be considered one of the most documented techniques in the literature. It consists of inserting graft material, covered by a membrane, into bone defects to achieve adequate maintenance of the spaces and to enhance blood clot stabilization, osteoblast proliferation, and new bone formation [1]. Growth factors and cytokines released by the blood clot attract monocytes, macrophages, and osteochondroblast precursors, which enhance new blood vessel formation after bone regeneration [2].
Different graft materials have been used for bone regeneration, such as autologous bone, alloplastic, and xenoplastic materials [3]. Xenoplastic materials are the most commonly used due to their high availability and cost–benefit ratio. These materials offer stable bone volume maintenance, and several studies have shown that demineralized bovine bone material (DBBM) particles are osteoconductive and integrate well with newly formed bone [4]. Their long healing period and low percentage of new bone formation remain the main disadvantages of these graft materials [5]. In modern regenerative surgery, the use of graft materials with bioactive components is showing notable results as it induces activation of intracellular and extracellular molecular signaling pathways to promote tissue healing by accelerating the mechanisms of osteogenesis and improving the entire regenerative process [6]. One of the most commonly used bioactive components is hyaluronic acid (HA). HA is a high-molecular-weight polysaccharide that is an important component of the extracellular matrix (ECM) and is found in many different tissues of the human body [7]. HA is able to interact with proteoglycans and other bioactive molecules, is immunologically inert, and has a stimulating effect on angiogenesis [8]. HA maintains the viscoelasticity and the physical form of the ECM; it both supports its structure and functions as a lubricant [9].
It is widely recognized that the biological effects of HA are significantly influenced by its molecular size, with low-molecular-weight and high-molecular-weight HA typically inducing opposite effects [10,11]. Chen et al. (2016) provided biological evidence that high-molecular-weight HA enhances early mineralization of dental pulp cells through CD44 mediation [12].
Due to its physicochemical and biological properties, HA has been combined with various grafting materials in GBR. Combining xenograft granules with HA creates a putty bone grafting material that can improve surgical handling properties for the bone reconstruction of defects with demanding defect morphologies. Studies have shown that HA promotes osteogenesis [13]. HA improves bone growth by acting as a carrier for osteoinductive compounds [14] and promotes uniform distribution and greater density of the newly formed bone, thus altering the morphology of the scaffold and improving mineralization [15]. In the study of Kim JJ et al. (J Periodontal 2016) [16], the application of HA in extraction sockets with chronic pathology showed significantly increased bone formation compared to the control. The same group in a subsequent study (Kim JJ et al. J Periodontal 2019) [17] compared the effect of HA and BMP-2 on endodontic–periodontic lesions and observed alveolar bone overgrowth in both experimental groups.
The principal cell surface receptor for HA in the human body is CD44, a transmembrane glycoprotein distributed in various cells, such as osteocytes, where it is a sensitive marker of osteocytic differentiation [18] or cementoblasts and periodontal ligament cells (PDL) [19]. CD44 plays an important role in the proliferation and mineralization of PDL and, furthermore, shows how HA promotes cell viability, mineralization, and upregulation over a longer period of time, as well as the expression of mineralization-associated genes in cementoblasts [20,21].
Since it is a natural component of the ECM, when HA is combined with other materials, it makes the surfaces of the graft biomimetic, promoting mesenchymal migration [22], adhesion, proliferation, and differentiation [23]. The use of HA combined with bone graft materials also offers advantages due to its antimicrobial properties on pathogens such as staphylococcus, streptococcus, Pseudomonas aeruginosa, Enterococcus, and S. mutants [24].
The aim of this systematic review and meta-analysis was to assess possible histomorphometric differences in new bone formation and in the remaining graft particles when HA was added and mixed with graft materials in bone regeneration.

2. Materials and Methods

2.1. Protocol and Registration

This review was registered at the International Prospective Register of Systematic Reviews (PROPERO) of the National Institute of Health Research (registration number CRD42024530030). This review was reported according to the “Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA)” guidelines (Page et al. 2021) [25].

2.2. Population, Intervention, Comparison, Outcomes, and Study Design

The PICOS (Population, Intervention, Comparison, Outcomes, and Study design) format was used to establish the research question: “can biomaterials alone in regenerative surgery procedures (I), in partially edentulous patients (P), have the same histomorphometric results (O), in randomized clinical trials (S), as the use of biomaterials in association with HA (C)?”.

2.3. Inclusion and Exclusion Criteria

Before the start of the study, the inclusion and exclusion criteria were identified. To be included in the review, the article had to be written in the English language, a randomized clinical trial in humans, and had to contain the results of histomorphometric analyses of new bones. Systematic reviews, nonrandomized studies, commentaries, letters to the editor, in vitro studies, studies in animal models, studies where HA was not mixed with biomaterial, and studies that did not report histomorphometric results of the new bone in the research protocol were excluded.

2.4. Types of Intervention

The analyzed studies were randomized clinical trials or split-mouth randomized clinical trials in humans. The test group was treated with grafting materials in association with HA, and the control group was treated with grafting materials alone for bone regeneration.

2.5. Outcome Measures

The primary outcome of this systematic review and meta-analysis was to assess possible histomorphometric differences in new bone formation and in the remaining graft particles when HA was added and mixed with graft materials in bone regeneration.

2.6. Search Strategy

Electronic research was performed with MEDLINE databases and involved studies published up to 29 February 2024. The following combination of words were used: “hyaluronic acid and bone regeneration and dentistry”. In addition, bibliographies of the included articles were analyzed and cross-checked.

2.7. Selection Criteria and Data Analysis

Full-text screening, study selection, and data extraction were performed in duplicate, and disagreements were resolved by consensus. The analyzed studies were randomized clinical trials on human subjects assessing histomorphometric changes in sites requiring bone regeneration after treatment with DBBM or xenograft with or without the use of hyaluronic acid.

2.8. Risk of Bias

The quality of the included studies was assessed independently by the authors by means of Cochrane Collaboration’s tool 2. This tool was used to assess any potential risk of bias in the included RCTs [26]. The possible outcomes were a study with a low risk of bias, which provided all the required information about the investigated parameters; a study with a moderate risk of bias, which did not provide all the information required to fulfill the review process; and a study with a high risk of bias, which was missing more than 2 parameters.

2.9. Statistical Analysis

Meta-analyses were performed using the fixed and random effects model to identify significant changes in new bone formation and in the remaining graft particles. The Egger test, Cochran’s Q-statistic, and the I2 statistic were used to assess any publication bias and to calculate heterogeneity between the included studies. p-values < 0.05 were considered statistically significant. I2 values of 25%, 50%, and 75% corresponded to the cutoff points for low, moderate, and high degrees of heterogeneity, respectively. A minimum of 3 studies were needed to perform a meta-analysis.

3. Results

3.1. Included Studies

The search strategy resulted in 138 articles. After examining the title and abstract, 116 were excluded. Of the 22 potentially relevant articles, the full text was examined, and 3 articles were included in the analysis (Figure 1).
The three articles included in the review are presented in Table 1.

3.2. Excluded Studies

Nine articles among those examined dealt with periodontal surgery [30,31,32,33,34,35,36,37,38] and one with peri-implantitis [39]. Two articles were reviews [40,41], and one study was not randomized [42]. In two studies, HA was not mixed with biomaterials [43,44], and three other studies were excluded because there were no histomorphometric data [45,46,47]. One article was excluded because the standard deviation was not present in the histological results data [48]. All excluded articles are summarized in Table 2.

3.3. Study Characteristics

All selected studies were RCTs and published between 2014 and 2023. The risk of bias assessment reported a low risk of bias for the included studies (Figure 2).
One study was designed as split-mouth [27], evaluating the effect of two bone graft materials (pure, synthetic b-TCP granules with a grain size of 700e1400 mm and a putty material composed of pure, synthetic b-TCP granules with two types of grain size ranges, 125e250 mm and 500e700 mm, embedded in a sodium HA hydrogel matrix with a b-TCP: HA ratio of 10:1) on bone formation, bone matrix maturation, and osteoblast differentiation six months after maxillary sinus augmentation (MSA). In the study published by Velasco-Ortega et al. [28], the aim was to evaluate and compare, histomorphometrically and clinically, three different bone substitutes in the MSA. The studied materials were an organic bovine bone mineral (ABBM) and betatricalcium phosphate (TCP) with or without the addition of HA. A CBCT was performed before surgery and 9 months after the MSA before the implant surgery, where bone biopsies were performed for histomorphometric analyses. The last included study [29] involved patients who required implant placement in the upper arch. Patients were randomly divided into three groups (n = 12 each) receiving different treatments: injectable platelet-rich fibrin (I-PRF) with xenografts, HA with xenografts, or xenografts alone. Histomorphometric analysis was performed to determine the percentages of newly formed bone, mature bone, and residual grafts after 4 months (Table 3).

3.4. Included Studies’ Heterogeneity

The Egger test was not statistically significant for any of the investigated outcomes, the new bone formation, with or without HA (p = 0.244), and the remaining graft particles (p = 0.427). The test for heterogeneity revealed a Cochran’s Q-statistic index of 39.104 (new bone formation) and 3546 (remaining graft particles). The I2 statistic indexes were 93.7% (new bone) and 41.4% (remaining graft particles) (Figure 3 and Figure 4).

3.5. New Bone Formation

The effect size of HA in new bone formation was not statistically significant at 95% CI (Z = 1.734, p-value = 0.083, CI-,399; 6516) (Figure 5).

3.6. Remaining Graft Particles

The effect size of HA in the remaining graft particles was not statistically significant at 95% CI (Z = −1.042, p-value = 0.297, CI -,835; 255) (Figure 6).

4. Discussion

The aim of this systematic review and meta-analysis was to assess possible histomorphometric differences in new bone formation and in remaining graft particles when HA was added and mixed with graft materials in bone regeneration.
To the best of the authors’ knowledge, this is the first systematic review and meta-analysis assessing the potential effect of HA on bone regeneration procedures.
The main limitation of the present study was related to the paucity of well-conducted RCTs, which may be related to the novelty of the treatment. Nevertheless, three RCTs that assessed low sources of potential bias were included in the meta-analysis. Meta-analysis showed that the effect sizes of HA in new bone formation and in the remaining graft particles were not statistically significant at 95% CI (p-value = 0.083, CI -,399; 6516 and p-value = 0.297, CI -,835; 255).
After tooth loss, postextraction socket healing involves dimensional changes with loss of up to 50% of the original dimension [49], both in horizontal and vertical directions, especially on the buccal walls [50]. During this healing period, which lasts up to 12 months, the alveolar ridge can lose up to 5–7 mm [51]. Regenerative methods using growth factors, such as recombinant human platelet-derived growth factor-BB (rhPDGF-BB) and recombinant human bone morphogenetic proteins (rhBMPs), have been suggested. These techniques provide distinct benefits compared to traditional invasive surgical procedures for treating significant hard and soft tissue defects. The review by Galarraga-Vinueza et al. (2023) revealed that histomorphometric analyses have shown that rhBMP-2 significantly enhances new bone formation, increases bone marrow growth, and improves bone vascularity in grafted areas. Therefore, employing rhBMPs in bone grafting procedures can be advantageous for patients with impaired bone healing capacity, limited donor sites, a need for accelerated healing, or extensive bone defects. Additionally, numerous studies endorse the use of rhPDGF-BB for periodontal regeneration and root coverage procedures [52].
Since it is necessary to have an adequate bone volume and quantity of keratinized tissue to replace a lost tooth with an implant-supported crown in order to obtain good functional and esthetic results [53], in modern dentistry, it is imperative to anticipate the risk of hard and soft tissue loss and maintain adequate bone volume, especially in esthetic regions. It has been shown that inserting graft materials into the postextraction socket and covering them with a membrane to stabilize the graft and the clot and to avoid invasion of the soft tissues can prevent bone deficits and decrease physiological resorption [54,55]. This technique is called alveolar ridge preservation (ARP). In a 2023 split-mouth study [45], DBBM was used for ARP with and without HA in seven patients. Four months post-operatively, before implant placement, a Cone Beam Computed Tomography (CBCT) scan was performed. The results revealed that the combination of hydroxyapatite (HA) mixed with deproteinized bovine bone mineral (DBBM) exhibited significantly lower volumetric resorption. Additionally, the combination of DBBM with HA was associated with a greater level of homogenous incorporation of DBBM graft particles into the newly formed bone throughout the entire biopsy [45]. In another 2018 split-mouth study on ARP [46], 32 lower premolars were extracted from 16 patients. Sixteen sockets were filled with 1% hydroxyapatite (HA), while the other sixteen sockets were filled with a clot. Morphometric evaluation and fractal dimension analyses were conducted 30 and 90 days postsurgery using CBCT. Bone formation was more advanced in the sockets filled with HA after 30 days. However, after 90 days, both treated and control sockets exhibited similar bone density, suggesting that the biomaterial positively influenced the initial stages of alveolar healing. The test group filled with 1% HA showed higher levels of newly formed bone compared to the control group after 30 days, but no significant differences were observed after 90 days [46].
A previous meta-analysis by Domic et al. (2023) suggested that applying HyA could positively impact soft tissue healing following the nonsurgical extraction of normally erupted teeth. However, it appears that HyA does not significantly affect post-extraction alveolar ridge remodeling despite preclinical studies suggesting its potential to enhance bone formation [56].
In the posterior zone of the maxillary bone, pneumatization of the maxillary sinus can make implant rehabilitation difficult due to the lack of residual bone volume [57]. MSA is one of the best documented and most predictable bone regeneration techniques, with long-term implant success that is comparable to that achieved in native bone. The aim of this technique is to increase the bone volume in the posterior maxilla in order to place dental implants. In addition to an adequate volume, this should also guarantee correct bone quality to obtain immediate and long-term stability of the implants. The biomaterials used represent a k-factor in determining bone quality. Generally, two types of materials are used in MSA: autologous bone or bone substitutes, such as alloplastic or xenoplastic materials. Using bone substitutes simplifies the MSA procedure, as it avoids a second surgical site for bone harvesting and eliminates the risk of donor site morbidity [58,59]. In a previously published split-mouth study [43], 10 patients were treated with bilateral sinus floor elevation surgery using two techniques: hyaluronic acid and ultrasonic resorbable pin fixation (URPF) without any type of graft. CBCT was used to measure bone height at the sinus zone before and after 6 months of sinus floor elevation surgery. The idea was to use hydroxyapatite (HA) as a scaffold to provide optimal spacing and enhance vascular and cellular invasion. However, significant differences were observed in the height of the alveolar bone and the reduction in sinus volume on the URPF side [43].

5. Conclusions

Within the limitations of the present systematic review and meta-analysis, the addition of HA to the bone graft did not report significant changes in bone regeneration procedures in terms of new bone formation and residues, even if the included studies showed encouraging and promising results. The use of HA in bone regeneration may be useful in the future to stabilize the blood clot and enhance wound healing. However, more randomized clinical trials are needed to confirm such positive outcomes.

Author Contributions

Conceptualization: C.L., A.L., I.C., P.C., V.M. and C.A. Data curation and formal analysis: C.L., A.L. and P.C. Writing: C.L., A.L., I.C., P.C., V.M. and C.A. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Data Availability Statement

Data are available upon reasonable request from the corresponding author.

Conflicts of Interest

The auhots declare no conflict of interest.

References

  1. Wang, H.L.; Boyapati, L. “PASS” principles for predictable bone regeneration. Implant. Dent. 2006, 15, 8–17. [Google Scholar] [CrossRef] [PubMed]
  2. Brighton, C.T.; Hunt, R.M. Early histological and ultrastructural changes in medullary fracture callus. J. Bone Jt. Surg. Am. 1991, 73, 832–847. [Google Scholar] [CrossRef] [PubMed]
  3. Carosi, P.; Lorenzi, C.; Di Gianfilippo, R.; Papi, P.; Laureti, A.; Wang, H.L.; Arcuri, C. Immediate vs. Delayed Placement of Immediately Provisionalized Self-Tapping Implants: A Non-Randomized Controlled Clinical Trial with 1 Year of Follow-Up. J. Clin. Med. 2023, 12, 489. [Google Scholar] [CrossRef]
  4. Moussa, N.T.; Dym, H. Maxillofacial Bone Grafting Materials. Dent. Clin. N. Am. 2020, 64, 473–490. [Google Scholar] [CrossRef] [PubMed]
  5. De Risi, V.; Clementini, M.; Vittorini, G.; Mannocci, A.; De Sanctis, M. Alveolar ridge preservation techniques: A systematic review and meta-analysis of histological and histomorphometrical data. Clin. Oral Implants Res. 2015, 26, 50–68. [Google Scholar] [CrossRef] [PubMed]
  6. Majidinia, M.; Sadeghpour, A.; Yousefi, B. The roles of signaling pathways in bone repair and regeneration. J. Cell. Physiol. 2018, 233, 2937–2948. [Google Scholar] [CrossRef] [PubMed]
  7. Al-Khateeb, R.; Jelena, P. Hyaluronic acid: The reason for its variety of physiological and biochemical functional properties. Appl. Clin. Res. Clin. Trials Regul. Aff. 2019, 6, 112–159. [Google Scholar] [CrossRef]
  8. West, D.C.; Hampson, I.N.; Arnold, F.; Kumar, S. Angiogenesis induced by degradation products of hyaluronic acid. Science 1985, 228, 1324–1326. [Google Scholar] [CrossRef] [PubMed]
  9. Hemshekhar, M.; Thushara, R.M.; Chandranayaka, S.; Sherman, L.S.; Kemparaju, K.; Girish, K.S. Emerging roles of hyaluronic acid bioscaffolds in tissue engineering and regenerative medicine. Int. J. Biol. Macromol. 2016, 86, 917–928. [Google Scholar] [CrossRef] [PubMed]
  10. Vigetti, D.; Karousou, E.; Viola, M.; Deleonibus, S.; De Luca, G.; Passi, A. Hyaluronan: Biosynthesis and signaling. Biochim. Biophys. Acta 2014, 1840, 2452–2459. [Google Scholar] [CrossRef]
  11. Huang, L.; Cheng, Y.Y.; Koo, P.L.; Lee, K.M.; Qin, L.; Cheng, J.C.Y.; Kumta, S.M. The effect of hyaluronan on osteoblast proliferation and differentiation in rat calvarial-derived cell culture. J. Biomed. Mater. Res. A 2003, 66, 880–884. [Google Scholar] [CrossRef] [PubMed]
  12. Chen, K.L.; Yeh, Y.Y.; Lung, J.; Yang, Y.C.; Yuan, K. Mineralization Effect of Hyaluronan on Dental Pulp Cells via CD44. J. Endod. 2016, 42, 711–716. [Google Scholar] [CrossRef] [PubMed]
  13. Teixeira, E.R.; Boeckel, D.G.; Fulginiti, R.L.; Shinkai, R.S.A.; Machado, D. Mesenchymal stem cells and hyaluronic acid for bone grafting. Clin. Oral Implant. Res. 2018, 29, 12724. [Google Scholar] [CrossRef]
  14. Sudheesh Kumar, P.T.; Hashimi, S.; Saifzadeh, S.; Ivanovski, S.; Vaquette, C. Additively manufactured biphasic construct loaded with BMP-2 for vertical bone regeneration: A pilot study in rabbit. Mater. Sci. Eng. C Mater. Biol. Appl. 2018, 92, 554–564. [Google Scholar] [CrossRef] [PubMed]
  15. Al-Khateeb, R.; Olszewska-Czyz, I. Biological molecules in dental applications: Hyaluronic acid as a companion biomaterial for diverse dental applications. Heliyon 2020, 6, e03722. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  16. Kim, J.J.; Song, H.Y.; Ben Amara, H.; Kyung-Rim, K.; Koo, K.T. Hyaluronic Acid Improves Bone Formation in Extraction Sockets With Chronic Pathology: A Pilot Study in Dogs. J. Periodontol. 2016, 87, 790–795. [Google Scholar] [CrossRef] [PubMed]
  17. Kim, J.J.; Ben Amara, H.; Park, J.C.; Kim, S.; Kim, T.I.; Seol, Y.J.; Lee, Y.M.; Ku, Y.; Rhyu, I.C.; Koo, K.T. Biomodification of compromised extraction sockets using hyaluronic acid and rhBMP-2: An experimental study in dogs. J. Periodontol. 2019, 90, 416–424. [Google Scholar] [CrossRef] [PubMed]
  18. Hughes, D.E.; Salter, D.M.; Simpson, R. CD44 expression in human bone: A novel marker of osteocytic differentiation. J. Bone Miner. Res. 1994, 9, 39–44. [Google Scholar] [CrossRef] [PubMed]
  19. Bozic, D.; Grgurevic, L.; Erjavec, I.; Brkljacic, J.; Orlic, I.; Razdorov, G.; Grgurevic, I.; Vukicevic, S.; Plancak, D. The proteome and gene expression profile of cementoblastic cells treated by bone morphogenetic protein-7 in vitro. J. Clin. Periodontol. 2012, 39, 80–90. [Google Scholar] [CrossRef] [PubMed]
  20. Yeh, Y.; Yang, Y.; Yuan, K. Importance of CD44 in the proliferation and mineralization of periodontal ligament cells. J. Periodontal Res. 2014, 49, 827–835. [Google Scholar] [CrossRef] [PubMed]
  21. Hakki, S.S.; Bozkurt, S.B.; Sculean, A.; Božić, D. Hyaluronic acid enhances cell migration, viability, and mineralized tissue-specific genes in cementoblasts. J. Periodontal Res. 2024, 59, 63–73. [Google Scholar] [CrossRef] [PubMed]
  22. Zhu, H.; Mitsuhashi, N.; Klein, A.; Barsky, L.W.; Weinberg, K.; Barr, M.L.; Demetriou, A.; Wu, G.D. The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix. Stem. Cells 2006, 24, 928–935. [Google Scholar] [CrossRef] [PubMed]
  23. Tan, H.; Gong, Y.; Lao, L.; Mao, Z.; Gao, C. Gelatin/chitosan/hyaluronan ternary complex scaffold containing basic fibroblast growth factor for cartilage tissue engineering. J. Mater. Sci. Mater. Med. 2007, 18, 1961–1968. [Google Scholar] [CrossRef] [PubMed]
  24. Romanò, C.L.; De Vecchi, E.; Bortolin, M.; Morelli, I.; Drago, L. Hyaluronic Acid and Its Composites as a Local Antimicrobial/Antiadhesive Barrier. J. Bone Jt. Infect. 2017, 2, 63–72. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  25. Moher, D.; Liberati, A.; Tetzlaff, J.; Altman, D.G.; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009, 6, e1000097. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  26. Higgins, J.P.; Altman, D.G.; Gøtzsche, P.C.; Jüni, P.; Moher, D.; Oxman, A.D.; Savovic, J.; Schulz, K.F.; Weeks, L.; Sterne, J.A.; et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 2011, 343, d5928. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  27. Stiller, M.; Kluk, E.; Bohner, M.; Lopez-Heredia, M.A.; Müller-Mai, C.; Knabe, C. Performance of β-tricalcium phosphate granules and putty, bone grafting materials after bilateral sinus floor augmentation in humans. Biomaterials 2014, 35, 3154–3163. [Google Scholar] [CrossRef] [PubMed]
  28. Velasco-Ortega, E.; Valente, N.A.; Iezzi, G.; Petrini, M.; Derchi, G.; Barone, A. Maxillary sinus augmentation with three different biomaterials: Histological, histomorphometric, clinical, and patient-reported outcomes from a randomized controlled trial. Clin. Implant. Dent. Relat. Res. 2021, 23, 86–95. [Google Scholar] [CrossRef] [PubMed]
  29. Abaza, G.; Abdel Gaber, H.K.; Afifi, N.S.; Adel-Khattab, D. Injectable platelet rich fibrin versus hyaluronic acid with bovine derived xenograft for alveolar ridge preservation. A randomized controlled clinical trial with histomorphometric analysis. Clin. Implant. Dent. Relat. Res. 2024, 26, 88–102. [Google Scholar] [CrossRef] [PubMed]
  30. Ballini, A.; Cantore, S.; Capodiferro, S.; Grassi, F.R. Esterified hyaluronic acid and autologous bone in the surgical correction of the infra-bone defects. Int. J. Med. Sci. 2009, 6, 65–71. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  31. Božić, D.; Ćatović, I.; Badovinac, A.; Musić, L.; Par, M.; Sculean, A. Treatment of Intrabony Defects with a Combination of Hyaluronic Acid and Deproteinized Porcine Bone Mineral. Materials 2021, 14, 6795. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  32. de Santana, R.B.; de Santana, C.M. Human intrabony defect regeneration with rhFGF-2 and hyaluronic acid—A randomized controlled clinical trial. J. Clin. Periodontol. 2015, 42, 658–665. [Google Scholar] [CrossRef] [PubMed]
  33. Mamajiwala, A.S.; Sethi, K.S.; Raut, C.P.; Karde, P.A.; Mamajiwala, B.S. Clinical and radiographic evaluation of 0.8% hyaluronic acid as an adjunct to open flap debridement in the treatment of periodontal intrabony defects: Randomized controlled clinical trial. Clin. Oral Investig. 2021, 25, 5257–5271. [Google Scholar] [CrossRef] [PubMed]
  34. Sehdev, B.; Bhongade, M.L.; Ganji, K.K. Evaluation of effectiveness of hyaluronic acid in combination with bioresorbable membrane (poly lactic acid-poly glycolic acid) for the treatment of infrabony defects in humans: A clinical and radiographic study. J. Indian Soc. Periodontol. 2016, 20, 50–56. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  35. Engström, P.E.; Shi, X.Q.; Tronje, G.; Larsson, A.; Welander, U.; Frithiof, L.; Engstrom, G.N. The effect of hyaluronan on bone and soft tissue and immune response in wound healing. J. Periodontol. 2001, 72, 1192–1200. [Google Scholar] [CrossRef] [PubMed]
  36. Briguglio, F.; Briguglio, E.; Briguglio, R.; Cafiero, C.; Isola, G. Treatment of infrabony periodontal defects using a resorbable biopolymer of hyaluronic acid: A randomized clinical trial. Quintessence Int. 2013, 44, 231–240. [Google Scholar] [CrossRef] [PubMed]
  37. Pilloni, A.; Rojas, M.A.; Marini, L.; Russo, P.; Shirakata, Y.; Sculean, A.; Iacono, R. Healing of intrabony defects following regenerative surgery by means of single-flap approach in conjunction with either hyaluronic acid or an enamel matrix derivative: A 24-month randomized controlled clinical trial. Clin. Oral Investig. 2021, 25, 5095–5107. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  38. Vanden Bogaerde, L. Treatment of infrabony periodontal defects with esterified hyaluronic acid: Clinical report of 19 consecutive lesions. Int. J. Periodontics Restorative Dent. 2009, 29, 315–323. [Google Scholar] [PubMed]
  39. Kaya, O.A.; Muglali, M.; Torul, D.; Kaya, I. Peri-implant bone defects: A 1-year follow-up comparative study of use of hyaluronic acid and xenografts. Niger. J. Clin. Pract. 2019, 22, 1388–1395. [Google Scholar] [CrossRef] [PubMed]
  40. D’Albis, G.; D’Albis, V.; Palma, M.; Plantamura, M.; Nizar, A.K. Use of hyaluronic acid for regeneration of maxillofacial bones. Genesis 2022, 60, e23497. [Google Scholar] [CrossRef] [PubMed]
  41. Ostos-Aguilar, B.I.; Pinheiro Furquim, C.; Muniz, F.W.M.G.; Faveri, M.; Meza-Mauricio, J. Clinical efficacy of hyaluronic acid in the treatment of periodontal intrabony defect: A systematic review and meta-analysis. Clin. Oral Investig. 2023, 27, 1923–1935. [Google Scholar] [CrossRef] [PubMed]
  42. Lorenz, J.; Barbeck, M.; Kirkpatrick, C.J.; Sader, R.; Lerner, H.; Ghanaati, S. Injectable Bone Substitute Material on the Basis of β-TCP and Hyaluronan Achieves Complete Bone Regeneration While Undergoing Nearly Complete Degradation. Int. J. Oral Maxillofac. Implants 2018, 33, 636–644. [Google Scholar] [CrossRef] [PubMed]
  43. Göçmen, G.; Atalı, O.; Aktop, S.; Sipahi, A.; Gönül, O. Hyaluronic Acid Versus Ultrasonic Resorbable Pin Fixation for Space Maintenance in Non-Grafted Sinus Lifting. J. Oral Maxillofac. Surg. 2016, 74, 497–504. [Google Scholar] [CrossRef] [PubMed]
  44. Eeckhout, C.; Ackerman, J.; Glibert, M.; Cosyn, J. A randomized controlled trial evaluating hyaluronic acid gel as wound healing agent in alveolar ridge preservation. J. Clin. Periodontol. 2022, 49, 280–291. [Google Scholar] [CrossRef] [PubMed]
  45. Husseini, B.; Friedmann, A.; Wak, R.; Ghosn, N.; Khoury, G.; El Ghoul, T.; Abboud, C.K.; Younes, R. Clinical and radiographic assessment of cross-linked hyaluronic acid addition in demineralized bovine bone based alveolar ridge preservation: A human randomized split-mouth pilot study. J. Stomatol. Oral Maxillofac. Surg. 2023, 124, 101426. [Google Scholar] [CrossRef] [PubMed]
  46. Alcântara, C.E.P.; Castro, M.A.A.; Noronha, M.S.; Martins-Junior, P.A.; Mendes, R.M.; Caliari, M.V.; Mesquita, R.A.; Ferreira, A.J. Hyaluronic acid accelerates bone repair in human dental sockets: A randomized triple-blind clinical trial. Braz. Oral Res. 2018, 32, e84. [Google Scholar] [CrossRef] [PubMed]
  47. Baldini, A.; Zaffe, D.; Nicolini, G. Bone-defects healing by high-molecular hyaluronic acid: Preliminary results. Ann. Stomatol. 2010, 1, 2–7. [Google Scholar] [PubMed] [PubMed Central]
  48. Kauffmann, F.; Fickl, S.; Sculean, A.; Fischer, K.R.; Friedmann, A. Alveolar ridge alterations after lateral guided bone regeneration with and without hyaluronic acid: A prospective randomized trial with morphometric and histomorphometric evaluation. Quintessence Int. 2023, 54, 712–722. [Google Scholar] [CrossRef] [PubMed]
  49. Lorenzi, C.; Lio, F.; Papi, P.; Mazzetti, V.; Laureti, A.; Arcuri, C. Clinical Reliability of Complete-Arch Fixed Prostheses Supported by Narrow-Diameter Implants to Support Complete-Arch Restorations. Appl. Sci. 2023, 13, 538. [Google Scholar] [CrossRef]
  50. Tan, W.L.; Wong, T.L.; Wong, M.C.; Lang, N.P. A systematic review of post-extractional alveolar hard and soft tissue dimensional changes in humans. Clin. Oral Implants Res. 2012, 23 (Suppl. 5), 1–21. [Google Scholar] [CrossRef] [PubMed]
  51. Schropp, L.; Wenzel, A.; Kostopoulos, L.; Karring, T. Bone healing and soft tissue contour changes following single-tooth extraction: A clinical and radiographic 12-month prospective study. Int. J. Periodontics Restorative Dent. 2003, 23, 313–323. [Google Scholar] [PubMed]
  52. Galarraga-Vinueza, M.E.; Barootchi, S.; Nevins, M.L.; Nevins, M.; Miron, R.J.; Tavelli, L. Twenty-five years of recombinant human growth factors rhPDGF-BB and rhBMP-2 in oral hard and soft tissue regeneration. Periodontology 2000 2024, 94, 483–509. [Google Scholar] [CrossRef] [PubMed]
  53. Carosi, P.; Ottria, L.; Lio, F.; Laureti, A.; Papi, P. The health of soft tissues around four dental implants loaded immediately supporting a 4-year-old fixed screw-retained prosthesis. J. Biol. Regul. Homeost. Agents 2021, 35 (Suppl. 1), 57–66. [Google Scholar] [CrossRef] [PubMed]
  54. Pozzi, A.; Carosi, P.; Gallucci, G.O.; Nagy, K.; Nardi, A.; Arcuri, L. Accuracy of complete-arch digital implant impression with intraoral optical scanning and stereophotogrammetry: An in vivo prospective comparative study. Clin. Oral Implants Res. 2023, 34, 1106–1117. [Google Scholar] [CrossRef]
  55. Leggeri, A.; Carosi, P.; Mazzetti, V.; Arcuri, C.; Lorenzi, C. Techniques to Improve the Accuracy of Intraoral Digital Impression in Complete Edentulous Arches: A Narrative Review. Appl. Sci. 2023, 13, 7068. [Google Scholar] [CrossRef]
  56. Domic, D.; Bertl, K.; Lang, T.; Pandis, N.; Ulm, C.; Stavropoulos, A. Hyaluronic acid in tooth extraction: A systematic review and meta-analysis of preclinical and clinical trials. Clin. Oral Investig. 2023, 27, 7209–7229. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  57. Carosi, P.; Ferrigno, N.; Arcuri, C.; Laureti, M. Computer-Aided Surgery and Immediate Loading to Rehabilitate Complete Arch with Four Dental Implants and Fixed Screw-Retained Prosthesis Up to 4 Years in Function: A Retrospective Study. Int. J. Oral Maxillofac. Implants 2021, 36, 1180–1187. [Google Scholar] [CrossRef]
  58. Zijderveld, S.A.; Zerbo, I.R.; van den Bergh, J.P.; Schulten, E.A.; ten Bruggenkate, C.M. Maxillary sinus floor augmentation using a beta-tricalcium phosphate (Cerasorb) alone compared to autogenous bone grafts. Int. J. Oral Maxillofac. Implants 2005, 20, 432–440. [Google Scholar] [PubMed]
  59. Kalk, W.W.; Raghoebar, G.M.; Jansma, J.; Boering, G. Morbidity from iliac crest bone harvesting. J. Oral Maxillofac. Surg. 1996, 54, 1424–1429. [Google Scholar] [CrossRef] [PubMed]
Dentistry 12 00263 g001
Figure 1. PRISMA (Preferred Reporting Items for Systematic Review and Meta-Analyses) search strategy flow chart.
Figure 1. PRISMA (Preferred Reporting Items for Systematic Review and Meta-Analyses) search strategy flow chart.
Dentistry 12 00263 g001
Dentistry 12 00263 g002
Figure 2. Quality assessment of the included studies following Cochrane Collaboration’s tool for assessing risk of bias in randomized trials. Green = low risk; red = high risk [27,28,29].
Figure 2. Quality assessment of the included studies following Cochrane Collaboration’s tool for assessing risk of bias in randomized trials. Green = low risk; red = high risk [27,28,29].
Dentistry 12 00263 g002
Dentistry 12 00263 g003
Figure 3. Funnel plot for new bone formation [27,28,29].
Figure 3. Funnel plot for new bone formation [27,28,29].
Dentistry 12 00263 g003
Dentistry 12 00263 g004
Figure 4. Funnel plot for remaining graft particle [27,28,29].
Figure 4. Funnel plot for remaining graft particle [27,28,29].
Dentistry 12 00263 g004
Dentistry 12 00263 g005
Figure 5. Forest plot for new bone formation [27,28,29].
Figure 5. Forest plot for new bone formation [27,28,29].
Dentistry 12 00263 g005
Dentistry 12 00263 g006
Figure 6. Forest plot for remaining graft particles [27,28,29].
Figure 6. Forest plot for remaining graft particles [27,28,29].
Dentistry 12 00263 g006
Table 1. Main charachteristics of the included studies.
Table 1. Main charachteristics of the included studies.
StudyStudy DesignNumber of HA Cases% New Bone HA% Particles HANumber of Control Cases% New Bone Control% Particles Control
Stiller et al., 2014 [27]Randomized split-mouth730.129.5717.432.9
Velasco-Ortega et al., 2020 [28]Randomized controlled trial823.297.17823.857.17
Abaza et al., 2023 [29]Randomized controlled trial1256.662.631224.052.71
Table 2. Ecluded studies and reason for exclusion.
Table 2. Ecluded studies and reason for exclusion.
StudiesExclusion Reason
Ballini et al., 2009 [30]
Božić et al., 2021 [31]
de Santana et al., 2015 [32]
Mamajiwala et al., 2021 [33]
Sehdev et al., 2016 [34]
Engström et al., 2001 [35]
Briguglio et al., 2013 [36]
Pilloni et al., 2021 [37]
Vanden Bogaerde et al., [38]		The focus of these studies is periodontal surgery
Kaya et al., 2019 [39]The main focus was not bone regeneration
D’Albis et al., 2022 [40]
Ostos-Aguilar et al., 2023 [41]
Lorenz et al., 2018 [42]		Study design different from RCTs
Göçmen et al., 2016 [43]
Eeckhout et al., 2022 [44]		HA was not mixed with biomaterials
Husseini et al., 2023 [45]
Alcântara et al., 2018 [46]
Baldini et al., 2010 [47]		No histomorphometric data were reported
Kauffmann et al., 2023 [48]Missing statistical data to be included in meta-analysis
Table 3. Detailed protocol of the included studies.
Table 3. Detailed protocol of the included studies.
StudyBone Graft MaterialsPurpose of the StudyStudy ProtocolHistomorphometric Results
Stiller et al., 2014 [27]TCP-G: CEROS TCP Granules, Mathys Ltd., Switzerland.
Pure, synthetic b-TCP granules with a grain size of 700–1400 mm.
TCP-P: CEROS TCP Putty, Mathys Ltd., Switzerland.
Putty material composed of pure, synthetic b-TCP granules with two types of grain size ranges, i.e., 125–250 mm and 500–700 mm, embedded in a sodium HA hydrogel matrix with a b-TCP:HA ratio of 10:1.		Evaluate the effect of these two bone graft materials on bone formation, bone matrix
maturation and osteoblast differentiation six months after MSA.		CBCT was performed preoperatively, post-operatively, and six months after MSA for a 3D assessment of the sinus floor anatomy and bone volume. Before the implant surgery, bone biopsies were performed for histomorphometric analyses.Six months after SFA:
TCP-G:
Bone: 17.4 ± 3.3%,
Particle: 32.9 ± 2.4%
Marrow spaces: 49.7 ± 2.6%.
TCP-P:
Bone: 30.1 ± 3.1%
Particle: 29.5 ± 3.0%
Marrow spaces: 40.5 ± 3.2%
Velasco-Ortega et al., 2020 [28]Control Group: Bio-Oss Cancellous, Geistlich, Wolhusen, Switzerland.
Demineralized Bovine Bone Mineral
Test group: Hyadent BG, Regedent.
TCP in the test group plus crosslinked HA with a ratio of 2:1.		Evaluate and compare, histomorphometrically and clinically, different bone substitutes in the MSA.A CBCT was performed before surgery and 9 months after the MSA before the implant surgery, where bone biopsies were performed for histomorphometric analyses.Control Group:
New bone: 25.97 ± 2.79%
Particle: 32.19 ± 1.52%
Marrow spaces: 41.99 ± 3.44%
Test:
New bone: 23.29 ± 2.01%
Particle: 7.47 ± 3.59%
Marrow spaces: 69.80 ± 2.51%
Abaza et al., 2023 [29]Group 1: crosslinked HA solution (Perfecta) + cerabone®, Straumann, Germany.
Group 2: cerabone®, Straumann, Germany.		Compare the effectiveness of HA in combination with xenografts for ARP versus xenografts alone.Cone beam CT scans were performed preoperatively and 4 months post-operatively to measure radiographic bone gain. Histological assessment of core bone biopsies was performed 4 months post-operatively.Group 1:
New bone: 56.66 ± 7.35%
(Mature bone: 18.26 ± 4.44%)
Particle: 2.63 ± 1.27%
Group 2:
New bone: 24.05 ± 3.64%
(Mature bone: 2.41 ± 1.36%)
Particle: 2.71 ± 1.24%
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Lorenzi, C.; Leggeri, A.; Cammarota, I.; Carosi, P.; Mazzetti, V.; Arcuri, C. Hyaluronic Acid in Bone Regeneration: Systematic Review and Meta-Analysis. Dent. J. 2024, 12, 263. https://doi.org/10.3390/dj12080263

AMA Style

Lorenzi C, Leggeri A, Cammarota I, Carosi P, Mazzetti V, Arcuri C. Hyaluronic Acid in Bone Regeneration: Systematic Review and Meta-Analysis. Dentistry Journal. 2024; 12(8):263. https://doi.org/10.3390/dj12080263

Chicago/Turabian Style

Lorenzi, Claudia, Andrea Leggeri, Ilaria Cammarota, Paolo Carosi, Vincenzo Mazzetti, and Claudio Arcuri. 2024. "Hyaluronic Acid in Bone Regeneration: Systematic Review and Meta-Analysis" Dentistry Journal 12, no. 8: 263. https://doi.org/10.3390/dj12080263

APA Style

Lorenzi, C., Leggeri, A., Cammarota, I., Carosi, P., Mazzetti, V., & Arcuri, C. (2024). Hyaluronic Acid in Bone Regeneration: Systematic Review and Meta-Analysis. Dentistry Journal, 12(8), 263. https://doi.org/10.3390/dj12080263

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop